STOCK TITAN

INVO Fertility: Glenbrook reports 1.4% stake

The reported position is 35,000 shares as of September 30, compared with 40,000 shares Glenbrook may have been deemed to beneficially own as of June 30.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

For INVO Fertility, Inc. (IVF), reporting person Glenbrook Capital Management reported beneficial ownership of 35,000 common shares, or 1.4%, with shared voting and dispositive power, based on information as of September 30, 2026. Glenbrook may have been deemed to beneficially own 40,000 shares, approximately 1.7%, as of June 30, 2026. The reported percentage is calculated using 2,506,969 shares outstanding as of August 14, 2026.

Shares beneficially owned 35,000 shares Based on information as of September 30, 2026
Percent of class 1.4% Based on information as of September 30, 2026
Shares potentially beneficially owned 40,000 shares Glenbrook may have been deemed to beneficially own this amount as of June 30, 2026
Percent of class Approximately 1.7% As of June 30, 2026
Shares outstanding 2,506,969 shares As of August 14, 2026; used to calculate the reported percentage
beneficially own regulatory
"may have been deemed to beneficially own 40,000 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Power regulatory
"Shared Voting Power 35,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 35,000.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INVO Fertility (IVF) shares did Glenbrook Capital Management report owning?

Glenbrook Capital Management reported beneficial ownership of 35,000 INVO Fertility common shares, or 1.4%, based on information as of September 30, 2026. The percentage was calculated using 2,506,969 shares outstanding as of August 14, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates





44984F807

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth above reflects information as of September 30, 2026. As of June 30, 2026, the Reporting Person may have been deemed to beneficially own 40,000 shares of Common Stock, representing approximately 1.7% of the outstanding shares of Common Stock as of such time.


SCHEDULE 13G



Glenbrook Capital Management
Signature:/s/ Robert W. Lishman
Name/Title:Robert W. Lishman, Director
Date:10/09/2026

Keep reading